ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

ClinicalTrials.gov ID: NCT05163314

Public ClinicalTrials.gov record NCT05163314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)

Study identification

NCT ID
NCT05163314
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
352 participants

Conditions and interventions

Interventions

  • Soticlestat Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 56 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 3, 2022
Primary completion
Sep 23, 2025
Completion
Sep 23, 2025
Last update posted
Oct 7, 2025

2022 – 2025

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Phoenix Childrens Hospital Phoenix Arizona 85016
Center For Neurosciences Tucson Arizona 85718
David Geffen School of Medicine at UCLA Los Angeles California 90095
University of California Benioff Children's Hospital San Francisco California 94143
Colorado Children's Hospital Denver Colorado 80218
Pediatric Neurology PA Winter Park Florida 32789
Clinical Integrative Research Center of Atlanta Atlanta Georgia 30328
Sunrise Pediatric Neurology Marietta Georgia 30066
University of Iowa Hospitals & Clinics - (CRS) Iowa City Iowa 52242
Midatlantic Epilepsy and Sleep Center Bethesda Maryland 20817
Minnesota Epilepsy Group PA Saint Paul Minnesota 55102
Institute of Neurology and Neurosurgery at Saint Barnabas, LLC Livingston New Jersey 07039
Boston Children's Health Physicians (BCHP) New York New York 10003
Northwell Health Physician Partners - Neurology at Lenox Hill New York New York 10016
NYU Comprehensive Epilepsy Center New York New York 10016
University of Toledo Toledo Ohio 43614
Oregon Health and Science University Portland Oregon 97239
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Thomas Jefferson University Philadelphia Pennsylvania 19107
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134
WellSpan Oncology Research York Pennsylvania 17403
Medical University of South Carolina Children Hospital - PIN Charleston South Carolina 29425
Cook Children's Medical Center - Jane and John Justin Neurosciences Center Fort Worth Texas 76104
University of Utah - Primary Children's Hospital - PPDS Salt Lake City Utah 84113
Seattle Children's Hospital Seattle Washington 98105
MultiCare Institute for Research & Innovation (Tacoma) Tacoma Washington 98402

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05163314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05163314 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →